Bone Marrow Transplant For Macrophage Activation Syndrome In Systemic Juvenile Idiopathic Arthritis​

Authors

Shailly Gaur, Children's Mercy Kansas CityFollow
Michael J. Holland, Children's Mercy Kansas CityFollow
J Allyson Hays, Children's Mercy HospitalFollow
Ibrahim A. Ahmed, Children's Mercy HospitalFollow

Publication Date

5-2023

Files

Abstract

7yo w/ systemic juvenile idiopathic arthritis who developed macrophage activation syndrome and interstitial lung disease non-responsive to steroids, immunosuppression, and directed biologics with significant adverse reactions who required chemotherapy and eventual bone marrow transplant leading to complete resolution of symptoms.

Disciplines

Pediatrics | Rheumatology

Notes

Presented at the American Society of Pediatric Hematology/Oncology (ASPHO) 2023 Conference; Fort Worth, TX; May 10th-13th, 2023.

Recommended Citation

Gaur, Shailly; Holland, Michael J.; Hays, J Allyson; and Ahmed, Ibrahim A., "Bone Marrow Transplant For Macrophage Activation Syndrome In Systemic Juvenile Idiopathic Arthritis​" (2023). Posters. 325.
https://scholarlyexchange.childrensmercy.org/posters/325